Impact of Immigration on Phenotype and Severity of Inflammatory Bowel Disease: A Prospective Cohort Study of Hispanics in the United States

Plenary Session 1: IBD / Small Intestine / Unclassified Wednesday, October 22 8:30 am – 10:15 am Moderators: Francis A. Farraye, MD, MSc, FACG Jonathan A. Leighton MD, FACG Oral 60. Impact of Immigration on Phenotype and Severity of Inflammatory ...

Health Outcomes of Ulcerative Colitis (UC) and Crohn’s Disease (CD) Patients Hospitalized With Human Cytomegalovirus (CMV) Disease

Plenary Session 1: IBD / Small Intestine / Unclassified Wednesday, October 22 8:30 am – 10:15 am Moderators: Francis A. Farraye, MD, MSc, FACG Jonathan A. Leighton MD, FACG Oral 62: Health Outcomes of Ulcerative Colitis (UC) and Crohn’s ...

Infliximab or Cyclosporine as Rescue Therapy in Patients With Severe Ulcerative Colitis Refractory to Steroids: A Systematic Review and Meta-Analysis

Plenary Session 2: IBD Monday, October 20 2:15 pm – 3:00 pm MODERATORS:     Uma Mahadevan, MD, FACG Sunanda V. Kane, MD, MSPH, FACG Oral 15: Infliximab or Cyclosporine as Rescue Therapy in Patients With Severe Ulcerative Colitis Refractory ...

The Risk of a Second Non-Melanoma Skin Cancer With Thiopurine and Anti-TNF Use in Inflammatory Bowel Disease

Plenary Session 1: IBD / Small Intestine / Unclassified Wednesday, October 22 8:30 am – 10:15 am Moderators: Francis A. Farraye, MD, MSc, FACG Jonathan A. Leighton MD, FACG Oral 63: The Risk of a Second Non-Melanoma Skin Cancer With Thiopurine ...

Colonoscopy Is Associated With a Reduced Risk of Colon Cancer and Mortality in Patients With Inflammatory Bowel Diseases

PRESIDENT’S PLENARY SESSION 2 Monday October 20 9:30 am – 10:30 am (Terrace Ballroom) Moderators:      Stephen B. Hanauer, MD, FACG John R. Saltzman, MD, FACG Oral 9: Colonoscopy Is Associated With a Reduced Risk of Colon Cancer ...

Safety of Vedolizumab Alone or With Concomitant Corticosteroids and/or Immunosuppressants in Patients With Ulcerative Colitis or Crohn’s Disease

Plenary Session 2: IBD Monday, October 20 2:15 pm – 3:00 pm MODERATORS:    Uma Mahadevan, MD, FACG Sunanda V. Kane, MD, MSPH, FACG Oral 16: Safety of Vedolizumab Alone or With Concomitant Corticosteroids and/or Immunosuppressants in Patients ...